| PERIOD ENDING | 30-Nov-08 | 30-Nov-07 | | Total Revenue | 6,957,021 | 6,434,288 | | Cost of Revenue | 1,199,436 | 1,044,574 | | | Gross Profit | 5,757,585 | 5,389,714 | | | Operating Expenses | | Research Development | 530,901 | 610,205 | | Selling General and Administrative | 1,884,896 | 2,155,188 | | Non Recurring |
-
| 391,119 | | Others | 1,595,615 | 950,165 | | | | Total Operating Expenses |
-
| 4,106,677 | | | | Operating Income or Loss | 1,746,173 | 1,283,037 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| | Earnings Before Interest And Taxes | 1,746,173 | 1,283,037 | | Interest Expense | 88,568 | 337,841 | | Income Before Tax | 1,657,605 | 945,196 | | Income Tax Expense | 594,692 | 356,566 | | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | 1,062,913 | 588,630 | | | Non-recurring Events | | Discontinued Operations | (135,163) |
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | 927,750 | 588,630 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | $927,750 | $588,630 |
|
0.29% Nasdaq 
Income Statement
